DOGE Eyes Potential Reversal: 4H Chart Shows iH&S Pattern Near $0.14

⬤ Recent chart analysis shows DOGE building what appears to be a classic reversal setup. The 4-hour chart reveals three distinct troughs forming below a downward-sloping resistance zone, with price action hovering around $0.14. What makes this interesting is how clearly the structure is taking shape—a left shoulder, a deeper head, and now what could be a developing right shoulder.

⬤ The neckline sitting overhead has proven to be a tough barrier. DOGE has tested it several times without breaking through, creating a well-defined resistance band near $0.15. The pattern shows price consolidating beneath this level, with recent candles suggesting attempts to build higher lows. Each rejection at the trendline highlights just how critical this zone has become for the asset’s near-term direction.

“Dogecoin 4H chart is shaping an inverse head and shoulders pattern—a structure often monitored as a possible signal of momentum change.”

⬤ What’s notable here is the symmetry in how the pattern has unfolded. After a series of downward moves, DOGE seems to be stabilizing. The curves on the chart show balanced price action across the formation, which is exactly what traders look for in these setups. The real question now is whether the right shoulder can hold its ground and whether buyers can push price back toward that neckline with enough force to break through.

⬤ This pattern matters because it reflects a potential shift in how short-term participants are viewing DOGE. If momentum picks up and price manages to reclaim the neckline, it could open the door to a recovery scenario. But until that happens, the focus remains on whether DOGE can sustain its current structure or continue trading within the broader downtrend.

My Take: The inverse head and shoulders on DOGE’s 4H chart is textbook in its formation. If the right shoulder holds and we see a clean break above that neckline, it could trigger meaningful upside. However, patterns only matter when confirmed—right now it’s a wait-and-see situation.

Source: Trader Tardigrade